Prospective analysis of mortality, morbidity, and risk factors in elderly diabetic subjects - Nagano Study

被引:38
作者
Katakura, M
Naka, M
Kondo, T
Nishii, N
Komatsu, M
Sato, Y
Yamauchi, K
Hiramatsu, K
Ikeda, M
Aizawa, T
Hashizume, K
机构
[1] Shinshu Univ, Ctr Hlth Serv, Matsumoto, Nagano 3908621, Japan
[2] Koshoku Chuo Hosp, Koshoku, Japan
[3] Asama Gen Hosp, Saku, Japan
[4] Nagano Chuo Hosp, Nagano, Japan
[5] Nagano Municipal Hlth Ctr, Nagano, Japan
[6] Nagoya Univ Hosp, Nagoya, Aichi, Japan
[7] Shinshu Univ, Sch Med, Dept Aging Med & Geriatr, Matsumoto, Nagano 390, Japan
关键词
D O I
10.2337/diacare.26.3.638
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVE - To clarify mortality and morbidity of intensively managed elderly diabetic individuals and to explore factors predicting mortality and diabetes-related end points. RESEARCH DESIGN AND METHODS - A total of 390 elderly (greater than or equal to65 years of age) outpatients with type 2 diabetes( 173 men and 217 women, mean age 73.0,years) were analyzed. The mean HbA(1c) upon entry was 6.8% (332 receiving oral hypoglycemics and/or insulin) and blood pressure upon entry was 136/74 mmHg (219 receiving antihypertensive drugs). The patients have been followed-up for 3 years with HbA(1c) <7.0% and blood pressure <145/80 mmHg as targets, with mortality and an aggregate of fatal and nonfatal diabetes-related events as end points. Mortality rate and causes of mortality, as well as risk factors for mortality and morbidity, were determined. RESULTS - The mortality rate, 2.9% per year, was comparable to that of the age- and sex-matched general population. Stroke was a leading cause of mortality after malignancy. By the univariate Cox proportional hazards model, only high serum creatinine and prior stroke were highly significant and strong risks for both end points. in those without prior stroke and receiving antihypertensive agents, the incidence of the diabetes-related end point based on their systolic blood pressure (SBP) quartile was U-shaped, with the nadir at the 3rd (SBP, 137-147 mmHg) and the peak at the 1st (SBP less than or equal to 125 mmHg) quartile. CONCLUSIONS - in well-controlled elderly diabetic subjects, there was no excessive mortality compared to the age- and sex-matched general population. Renal dysfunction and prior stroke were independent risks for mortality and morbidity. In those without prior stroke, a risk of too much lowering of blood pressure was suggested.
引用
收藏
页码:638 / 644
页数:7
相关论文
共 35 条
[1]
POSSIBLE LINK BETWEEN A LOW-PREVALENCE OF CARDIOVASCULAR-DISEASE AND MILD DYSLIPIDEMIA - A STUDY IN JAPANESE PATIENTS WITH TYPE-2 DIABETES [J].
AIZAWA, T ;
KOBAYASHI, M ;
SATO, Y ;
TOZUKA, M ;
ISHIHARA, F ;
OKADA, N ;
SHIGEMATSU, S ;
KOMATSU, M ;
HIRAMATSU, K ;
YAMAUCHI, K ;
KOMIYA, I ;
YAMADA, T ;
KANAI, M ;
HONDA, Z ;
YOSHIZAWA, K .
DIABETIC MEDICINE, 1993, 10 (05) :431-437
[2]
Risk factors determining mortality in older diabetics: A pilot study in Japanese patients [J].
Aizawa, T ;
Shigematsu, S ;
Hiramatsu, K ;
Komatsu, M ;
Yamauchi, K ;
Kaneko, T ;
Hashizume, K .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (04) :538-540
[3]
LONG-TERM GLYCEMIC CONTROL RELATES TO MORTALITY IN TYPE-II DIABETES [J].
ANDERSSON, DKG ;
SVARDSUDD, K .
DIABETES CARE, 1995, 18 (12) :1534-1543
[4]
RISK-FACTORS FOR DEVELOPMENT OF RETINOPATHY IN ELDERLY JAPANESE PATIENTS WITH DIABETES-MELLITUS [J].
ARAKI, A ;
ITO, H ;
HATTORI, A ;
INOUE, J ;
SATO, T ;
SHIRAKI, M ;
ORIMO, H .
DIABETES CARE, 1993, 16 (08) :1184-1186
[5]
Borch-Johnsen K, 1999, LANCET, V354, P617
[6]
BOWENJONES DE, 1997, TXB DIABETES, P11
[7]
Antihypertensive treatment and the J-curve [J].
Cruickshank, JM .
CARDIOVASCULAR DRUGS AND THERAPY, 2000, 14 (04) :373-379
[8]
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension [J].
Curb, JD ;
Pressel, SL ;
Cutler, JA ;
Savage, PJ ;
Applegate, WB ;
Black, H ;
Camel, G ;
Davis, BR ;
Frost, PH ;
Gonzalez, N ;
Guthrie, G ;
Oberman, A ;
Rutan, GH ;
Stamler, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (23) :1886-1892
[9]
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]
Gerstein HC, 2001, EVIDENCE BASED DIABE, P488